|

Acute Psychological and Physiological Effects of Cannabigerol

RECRUITINGN/ASponsored by Washington State University
Actively Recruiting
PhaseN/A
SponsorWashington State University
Started2024-10-28
Est. completion2026-10-31
Eligibility
Age21 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT06638996

Summary

The purpose of this study is to examine the acute effects of cannabigerol (CBG) on various psychological (e.g., anxiety, stress, mood, memory, impairment, intoxication, side effects) and physiological (blood pressure, cortisol, heart rate variability, electrodermal activity, pain tolerance, temperature) outcomes. Further, potential side effects of CBG (sleepiness/fatigue, dry mouth/eyes, increased appetite, and dizziness nausea) will be assessed. As such, the study is focused on better understanding some of the potentially beneficial and detrimental effects of CBG on humans.

Eligibility

Age: 21 Years+Healthy volunteers accepted
Inclusion Criteria:

21+ years of age Fluent in English

Exclusion Criteria:

Illiterate Serious psychiatric disorders (i.e., psychotic disorders, bipolar disorders) Intellectual disability Chronic neurological disorders (e.g., head injuries, brain tumors, Parkinson's disease) Diabetes Low blood pressure Pregnant or breastfeeding Recent illicit drug use (past 2 months) - does not include cannabis Dietary restrictions preventing them from eating muffin, yogurt, milk/juice

Conditions3

AnxietyHeart DiseaseNo Disease or Condition is Being Studied

Locations1 site

Washington State University - Pullman Campus
Pullman, Washington, 99163
Carrie Cuttler, Ph.D509-592-0151carrie.cuttler@wsu.edu

Browse More Trials

Heart Disease trialsAnxiety trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.